Breast Neoplasm Female, Financial Navigation, Financial Toxicity
Conditions
Brief summary
The goal of this study is to access the impact of a financial navigation program on improving financial toxicity among patients with breast cancer in China. The main questions it aims to answer are: * Does the intervention alleviate participants' financial toxicity? * Does the intervention enhance participants' cost-related health literacy? * Does the intervention improve participants' shared decision-making? * Does the intervention reduce participants' perceived stress? Researchers will compare the financial navigation program with usual oncology care to evaluate its effectiveness. Participants will receive the comprehensive financial navigation, including: * Needs assessment; * Cost-related health education, mainly including topics regarding communication of cost, treatment-related cost, health insurance policies, and family support; * Resource and service referral; * Personalized counseling.
Interventions
During hospitalization, participants will receive needs assessment, and one-on-one cost-related health education with a material booklet. Resource and service referral will be delivered face-to-face or by phone when the navigator identifies unaddressed problems. Within three months after discharge, participants will receive monthly follow-up phone calls and personalized counseling via WeChat.
Participants will receive usual oncology care during hospitalization and regular follow-up after discharge. Participants have the freedom to utilize any financial resources, but financial navigators do not offer comprehensive information support.
Sponsors
Study design
Eligibility
Inclusion criteria
* Newly diagnosed with breast cancer and undergoing surgery during this admission; * Female, age 18 years or older; * Receiving or expected to receive one or more of the following therapies: chemotherapy, radiotherapy, endocrine therapy, targeted therapy, and immunotherapy; * Eastern Cooperative Oncology Group Performance Status 0-2; * Provided informed consent to participate in this study.
Exclusion criteria
* Diagnosed with ductal carcinoma in situ (DCIS) * Presence of any serious psychiatric disorders; * Cognitive impairments; * Difficulty in reading, writing, or communicating in Chinese.
Design outcomes
Primary
| Measure | Time frame | Description |
|---|---|---|
| Financial toxicity | Baseline, 1st month and 3rd month since baseline | Financial toxicity will be measured with the Comprehensive Score for Financial Toxicity-Functional Assessment of Chronic Illness Therapy Version 2 (COST-FACIT-V2); lower scores (range, 0-44) indicating greater financial toxicity. |
| Material domain of financial toxicity | 1st month and 3rd month since baseline | Material domain of financial toxicity will be measured with 2 items adapted from the Medical Expenditure Panel Survey (MEPS). |
| Behavioral domain of financial toxicity | 1st month and 3rd month since baseline | Behavioral domain of financial toxicity will be measured by employment changes and cost-related nonadherence with 6 items adapted from MEPS and previous literature. |
Secondary
| Measure | Time frame | Description |
|---|---|---|
| Cost-related health literacy | Baseline, 1st month and 3rd month since baseline | The cost-related health literacy will be measured with homemade 10-item questionnaire, with higher scores indicating higher cost-related health literacy. |
| Shared decision-making | Baseline, 1st month and 3rd month since baseline | The shared decision-making ability will be measured with 9-item shared decision-making questionnaire (SDM-Q-9); higher scores (range, 0-45) indicating a greater degree of participants' involvement in shared decision-making. |
| Perceived stress | Baseline, 1st month and 3rd month since baseline | The perceived stress will be measured with Perceived Stress Scale (PSS); higher scores (range, 0-56) indicating greater perceived stress. |
Countries
China